title: Hemangiomas and other congenital malformations in infants exposed to antiretroviral therapy in utero.
authors.forename: Marco
authors.initials: M
authors.lastname: De Santis
authors.forename: Anna Franca
authors.initials: AF
authors.lastname: Cavaliere
authors.forename: Alessandro
authors.initials: A
authors.lastname: Caruso
authors.forename: Paola
authors.initials: P
authors.lastname: Villa
authors.forename: Enrica
authors.initials: E
authors.lastname: Tamburrini
authors.forename: Roberto
authors.initials: R
authors.lastname: Cauda
authors.forename: Carlo
authors.initials: C
authors.lastname: Fundaro
authors.forename: Orazio
authors.initials: O
authors.lastname: Genovese
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000453:epidemiology; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D006391:Hemangioma / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D011256:Pregnancy Outcome; D011297:Prenatal Exposure Delayed Effects
chemical_list: D019380:Anti-HIV Agents